235 related articles for article (PubMed ID: 2561214)
1. SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions.
Tsai BS; Villani-Price D; Keith RH; Zemaitis JM; Bauer RF; Leonard R; Djuric SW; Shone RL
Prostaglandins; 1989 Dec; 38(6):655-74. PubMed ID: 2561214
[TBL] [Abstract][Full Text] [Related]
2. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
[TBL] [Abstract][Full Text] [Related]
4. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
5. ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions.
Kishikawa K; Tateishi N; Maruyama T; Seo R; Toda M; Miyamoto T
Prostaglandins; 1992 Oct; 44(4):261-75. PubMed ID: 1332129
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors.
Feltner DE; Smith RH; Marasco WA
J Immunol; 1986 Sep; 137(6):1961-70. PubMed ID: 3018082
[TBL] [Abstract][Full Text] [Related]
7. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
Tsai BS; Keith RH; Villani-Price D; Kachur JF; Yang DC; Djuric SW; Yu S
J Pharmacol Exp Ther; 1994 Mar; 268(3):1499-505. PubMed ID: 8138960
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of 20-trifluoromethyl leukotriene B4 on human neutrophil functions.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Bauer RF; Leonard R; Abe Y; Nicolaou KC
Prostaglandins; 1989 Feb; 37(2):287-302. PubMed ID: 2543037
[TBL] [Abstract][Full Text] [Related]
9. 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.
Ternowitz T; Fogh K; Kragballe K
Skin Pharmacol; 1988; 1(2):93-9. PubMed ID: 2856182
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM
J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049
[TBL] [Abstract][Full Text] [Related]
11. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
[TBL] [Abstract][Full Text] [Related]
12. Role of resident mast cells and macrophages in the neutrophil migration induced by LTB4, fMLP and C5a des arg.
Ribeiro RA; Souza-Filho MV; Souza MH; Oliveira SH; Costa CH; Cunha FQ; Ferreira HS
Int Arch Allergy Immunol; 1997 Jan; 112(1):27-35. PubMed ID: 8980461
[TBL] [Abstract][Full Text] [Related]
13. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
Kurrasch R; Elfman F; Perez HD
J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
Harvath L; McCall CE; Bass DA; McPhail LC
J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
[TBL] [Abstract][Full Text] [Related]
15. Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist.
Marder P; Sawyer JS; Froelich LL; Mann LL; Spaethe SM
Biochem Pharmacol; 1995 May; 49(11):1683-90. PubMed ID: 7786309
[TBL] [Abstract][Full Text] [Related]
16. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.
Fretland DJ; Anglin CP; Bremer M; Isakson P; Widomski DL; Paulson SK; Docter SH; Djuric SW; Penning TD; Yu S
Inflammation; 1995 Apr; 19(2):193-205. PubMed ID: 7601505
[TBL] [Abstract][Full Text] [Related]
17. Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function.
Barnette MS; Rush J; Marshall LA; Foley JJ; Schmidt DB; Sarau HM
Biochem Pharmacol; 1994 Apr; 47(9):1661-7. PubMed ID: 8185681
[TBL] [Abstract][Full Text] [Related]
18. Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils.
Patrick RA; Peters PA; Issekutz AC
Agents Actions; 1993 Nov; 40(3-4):186-90. PubMed ID: 8023742
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
Fletcher MP
J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of a novel, orally active leukotriene B4 antagonist, SM-15178.
Ohmi N; Tani C; Yamada K; Fukui M
Inflammation; 1994 Apr; 18(2):129-40. PubMed ID: 8070898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
